From 2012 to 2022, the German market for contraceptives (based on hormones or spermicides) exhibited overall volatility. The market peaked at $562.69 million in 2014 before experiencing a notable decline and oscillating values, eventually decreasing to $486.16 million by 2022. The year-on-year variations highlighted periods of both significant growth and contraction. The compound annual growth rate (CAGR) for the last five years was -0.67%, indicating a slight overall downward trend.
Future trends to watch for include technological advancements in contraceptive methods, potential regulatory changes, shifts in consumer preferences towards non-hormonal options, and demographic shifts impacting demand. Monitoring these factors will be crucial for predicting future market movements.
How does Germany rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
